Non-motor symptoms evaluation in idiopathic cervical dystonia
Objective: To evaluate the prevalence of non-motor symptoms associated to idiopathic cervical dystonia (CD) in a sample of patients followed in a Brazilian Movement Disorders…Clinical outcomes of pallidal and subthalamic nucleus deep brain stimulation in isolated cranial and cranio-cervical dystonia
Objective: To evaluate clinical outcomes of deep brain stimulation (DBS) of globus pallidus internus (GPi) or subthalamic nucleus (STN) for isolated cranial or cranio-cervical dystonia.…Functional characterization of the upstream start codon in the GCH1 gene
Objective: To examine (1) the -22C > T point mutation which introduces a premature start codon upstream of the normal open reading frame (ORF) of…Parietal hand pseudodystonia: Significant functional gains with ultrasound-guided botulinum toxin treatments
Objective: Case report. Background: Symptomatic focal dystonia is most commonly secondary to lesions involving the basal ganglia. Previous reports have documented the occurrence of focal…Improvement of foot progression in cervical dystonia using osteopathic manipulative medicine
Objective: To determine if osteopathic manipulative medicine (OMM) can improve gait biomechanics in people with cervical dystonia (CD). Background: CD is a neurological disorder characterized…Cervical dystonia associated to Wallenberg syndrome
Objective: To describe, for the first time, a patient who developed cervical dystonia with signs and symptoms of a Wallenberg syndrome. Background: Secondary cervical dystonia…Heterozygous TUBB4A knock-out impairs mitochondrial motility in human neuronal model of DYT4
Objective: To study the role of tubulin beta 4A (TUBB4A) in mitochondrial motility in isogenic induced pluripotent stem cells (iPSC)-derived neurons. Background: Heterozygous mutations in…Assessment of need for treatment with botulinum toxin type A in cervical dystonia patients
Objective: To prospectively assess the interval in weeks between injection of botulinum toxin A (BoNTA) and patient-perceived need for the next injection for treatment of…Clinical and molecular features of DYT1 primary dystonia in a Peruvian population
Objective: To associate clinical data of dystonia patients with the TOR1-A gene mutation in Peru. Background: DYT1 dystonia is a severe generalized form of early-onset…Pseudodystonic upper limb secondary to thalamic lesions: Usefulness of ultrasound-guided botulinum toxin treatment
Objective: Case reports. Background: Although botulinum toxin is routinely used as first-line treatment for focal dystonias, little is known about its usefulness in the treatment…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.